Cryoport, Inc. (CYRX): Gross Profit
$83.05M
Year ended 2025-12-31
$87.77M
Trailing 12 months to 2026-06-30
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $83.05M | +19.2% | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | $69.66M | -7.5% | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | $75.33M | n/c | 2026-03-05, From 2023-01-01 |
| 2022-12-31 | $103.87M | +7.6% | 2025-03-07, From 2022-01-01 |
| 2021-12-31 | $96.58M | +165.8% | 2024-03-13, From 2021-01-01 |
| 2020-12-31 | $36.33M | +109.4% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $17.35M | +69.4% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $10.24M | +71.6% | 2020-03-10, From 2018-01-01 |
| 2017-12-31 | $5.97M | +92.4% | 2019-03-13, From 2017-01-01 |
| 2016-12-31 | $3.10M | n/a | 2018-03-08, From 2016-01-01 |
| No annual figure between 2015-03-31 and 2016-12-31. | |||
| 2015-03-31 | $1.17M | +167.5% | 2016-06-28, From 2014-04-01 |
| 2014-03-31 | $437.0K | n/m | 2015-05-19, From 2013-04-01 |
| 2013-03-31 | -$487.3K | n/m | 2014-06-25, From 2012-04-01 |
| 2012-03-31 | -$836.8K | n/m | 2013-06-25, From 2011-04-01 |
| 2011-03-31 | -$827.5K | n/a | 2012-06-27, From 2010-04-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | 2025-12-31 | $83.05M | +19.2% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $152.51M | +222.6% |
| Lifevantage Corp (LFVN) | 2026-06-30 | $141.61M | -22.9% |
| Maravai Lifesciences Holdings, Inc. (MRVI) | 2025-12-31 | $33.99M | -68.6% |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | $170.26M | +45.8% |
| Liquidia Corp (LQDA) | 2024-12-31 | $8.12M | -44.4% |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $113.56M | +7.5% |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $75.02M | +87.2% |
| Amarin Corp PLC (AMRN) | 2025-12-31 | $120.87M | +48.5% |
Compare CYRX, PHAT, LFVN, MRVI side by side · Screen every company in Pharmaceutical Preparations ↗